Your browser doesn't support javascript.
loading
Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma.
Paquette, Brice; Vernerey, Dewi; Chauffert, Bruno; Dabakuyo, Sandrine; Feuvret, Loic; Taillandier, Luc; Frappaz, Didier; Taillia, Hervé; Schott, Roland; Ducray, François; Fabbro, Michel; Tennevet, Isabelle; Ghiringhelli, François; Guillamo, Jean-Sébastien; Durando, Xavier; Castera, Daniel; Frenay, Marc; Campello, Chantal; Dalban, Cécile; Skrzypski, Jérome; Chinot, Olivier; Anota, Amélie; Bonnetain, Franck.
Afiliação
  • Paquette B; Methodological and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, EA 3181, France.
  • Vernerey D; Department of Digestive Surgery and Liver Transplantation, University Hospital of Besançon, Besançon, France.
  • Chauffert B; Methodological and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, EA 3181, France.
  • Dabakuyo S; Department of Medical Oncology, University Hospital, EA 4666, Amiens, France.
  • Feuvret L; Biostatistics and Quality of life Unit, Centre Georges François Leclerc, Dijon, France.
  • Taillandier L; Quality of Life in Oncology National Platform, Besançon, France.
  • Frappaz D; Department of Radiotherapy, Pitié-Salpetrière University Hospital, Paris, France.
  • Taillia H; Department of Neurology, University Hospital, Nancy, France.
  • Schott R; Department of Oncology, Leon Berard Centre for Fight against Cancer, Lyon, France.
  • Ducray F; Department of Neurology, HIA Val de Grace, Paris, France.
  • Fabbro M; Department of Oncology, Paul Strauss Centre for Fight against Cancer, Strasbourg, France.
  • Tennevet I; Department of Neurology, University Hospital, Lyon, France.
  • Ghiringhelli F; Department of Oncology, Val d'Aurelle Center for Fight against Cancer, Montpellier, France.
  • Guillamo JS; Department of Oncology, Henri Becquerel Center for Fight against Cancer, Rouen, France.
  • Durando X; Department of Oncology, GF Leclerc Center for Fight against Cancer, Dijon, France.
  • Castera D; Department of Neurology, University Hospital, Caen, France.
  • Frenay M; Department of Oncology, Jean Perrin Center for Fight against Cancer, Clermont-Ferrand, France.
  • Campello C; Clinique Saint Pierre, Perpignan, France.
  • Dalban C; Department of Oncology, Antoine Lacassagne Center for Fight against Cancer, Nice, France.
  • Skrzypski J; Department of Neurology, University Hospital, Nimes, France.
  • Chinot O; Biostatistics and Quality of life Unit, Centre Georges François Leclerc, Dijon, France.
  • Anota A; Methodology Unit, GF Leclerc Center for Fight against Cancer, Dijon, France.
  • Bonnetain F; Department of Neuro-Oncology, University Hospital La Timone, Marseille, France.
Cancer Med ; 5(8): 1753-64, 2016 08.
Article em En | MEDLINE | ID: mdl-27252150
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article